Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration.

about

Decreased Absorption of Dolutegravir and Tenofovir Disoproxil Fumarate, But Not Emtricitabine, in an HIV-Infected Patient Following Oral and Jejunostomy-Tube Administration.

Item

http://www.wikidata.org/entity/Q47761828

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Decreased Absorption of Dolute ...... junostomy-Tube Administration.

@en

Decreased Absorption of Dolute ...... junostomy-Tube Administration.

@nl

type

Item

label

Decreased Absorption of Dolute ...... junostomy-Tube Administration.

@en

Decreased Absorption of Dolute ...... junostomy-Tube Administration.

@nl

prefLabel

Decreased Absorption of Dolute ...... junostomy-Tube Administration.

@en

Decreased Absorption of Dolute ...... junostomy-Tube Administration.

@nl

P1476

Decreased Absorption of Dolute ...... ejunostomy-Tube Administration

@en

P2093

Alice K Pau

http://www.w3.org/2001/XMLSchema#string

Bria Bailey

http://www.w3.org/2001/XMLSchema#string

Frank Maldarelli

http://www.w3.org/2001/XMLSchema#string

Gayle Balba

http://www.w3.org/2001/XMLSchema#string

H Clifford Lane

http://www.w3.org/2001/XMLSchema#string

Jomy M George

http://www.w3.org/2001/XMLSchema#string

Katy L Garrett

http://www.w3.org/2001/XMLSchema#string

Megan Anderson

http://www.w3.org/2001/XMLSchema#string

Safia S Kuriakose

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA

Gastric and intestinal barrier impairment in tropical enteropathy and HIV: limited impact of micronutrient supplementation during a randomised controlled trial

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.

A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals.

HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition

Web resources for HIV type 1 genotypic-resistance test interpretation.

A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.

Acceptable plasma concentrations of raltegravir and etravirine when administered by gastrostomy tube in a patient with advanced multidrug-resistant human immunodeficiency virus infection

Intestinal barrier dysfunction in HIV infection: pathophysiology, clinical implications and potential therapies.

P304

e82-e89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1960

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kristina M Brooks

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28556353

http://www.w3.org/2001/XMLSchema#string

P932

5559318

http://www.w3.org/2001/XMLSchema#string